SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Vertex Pharmaceuticals (VRTX)
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
1169 64 0 VRTX
Emcee:  David Lieberman Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
319 Rick: All in all, it appears to me that amprenavir do compare well with older Miljenko Zuanic-9/28/1999
318 Monday September 27, 2:43 pm Eastern Time Company Press Release SOURCE: Vertescaram(o)uche-9/27/1999
317 Differences in Protease Inhibitor (PI) Phenotypic Susceptibility after Failure scaram(o)uche-9/27/1999
316 keep reading, beyond where you first start to say "did he get the wrong thscaram(o)uche-9/27/1999
315 Monday September 27, 8:42 am Eastern Time Company Press Release SOURCE: Vertescaram(o)uche-9/27/1999
314 [ parking info, market size ] 02:56 AM ET 09/23/99 Vets at Higher Risk for Hescaram(o)uche-9/24/1999
313 Mind if I post this whole thing??? YHOO news goes away too quickly for my likinLLCF-9/17/1999
312biz.yahoo.com <<Vertex and Hoechst Marion Roussel began collaborating in Miljenko Zuanic-9/17/1999
311 follow the subthread posts backwards........ Message 5029061scaram(o)uche-9/8/1999
310 Here's some sloppy work from zeneca. Take notice of the last sentence. ICasaubon-9/8/1999
309 Nice to run into you here as well as the SEPR board. There seem to be quite a fSidney Street-9/7/1999
308 <CSFB = Credit Suisse First Boston> Used to work there... have to go by LLCF-9/3/1999
307 CSFB = Credit Suisse First Boston, a pretty good pharma-biotech house. Alex ToSidney Street-9/3/1999
306 <<For all of you, Vertex, Alkermes and a few other Cambridge based biotecMiljenko Zuanic-9/3/1999
305 I like your pseudonym (Sidney Street, not Miljenko). For all of you, Vertex, Alrkrw-9/3/1999
304 So, what is their rating for VRTX? NEUTRAL!!! Miljenko PS: I do not follow Miljenko Zuanic-9/2/1999
303 Odd that the CSFB coverage initiation followed today with a $40 price target, tSidney Street-9/2/1999
302 Nice deal, indeed nice deal for VRTX! Definitely strong leadership in ICE inhibMiljenko Zuanic-9/1/1999
301 <<Talked about 3 of VRTX's compounds... all three potential blockbusMiljenko Zuanic-8/30/1999
300 Great Micheal King interview: Message 11092734 Talked about 3 of VRTX's cLLCF-8/28/1999
299 Thanks. <eom> Miljenko Zuanic-8/26/1999
298 the compound is completely synthetic. A chemical nomenclature program names itCasaubon-8/24/1999
297 <<It shares no structural similarities with MPA, while it does inhibit thMiljenko Zuanic-8/24/1999
296 good thread, but for the sake of accuracy: <i>J Acquir Immune Defic SyndCasaubon-8/23/1999
295 DAK: It is about time that this sucker start to move in right direction. It neMiljenko Zuanic-8/23/1999
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News